Delivery Order SPE2DB20D1100-SPE2DB25FE1N5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $7,389.26. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a $15,063.99 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This competitively awarded, firm fixed-price contract was executed on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside transaction, indicating the contract was open to all qualified...
- The Defense Logistics Agency awarded a delivery order valued at $3,774.90 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded transaction for pharmaceutical supplies to support...
- The Defense Logistics Agency awarded a delivery order valued at $15,910.60 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed price contract type. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a firm fixed price ceiling value of $11,979.29. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competitive, non-set-aside delivery order. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $1,254.19 on August 4, 2025. This firm fixed-price delivery order, which is scheduled for completion by August 5, 2025, represents a non-competitive set-aside award under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical distributor will perform the work at its corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,646.18 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of August 5, 2025. This contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $1,664.74. The award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive delivery order without set-aside designation. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,837.55 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units. This contract, awarded on July 18, 2025, utilizes a firm fixed price structure with an ultimate completion date of July 21, 2025. The award was not designated as a set-aside contract, indicating competitive award status. Performance will be conducted from AmerisourceBergen's Conshohocken, Pennsylvania location, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) with a ceiling value of $1,497.09. This is a firm fixed-price delivery order issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE1N5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count units) valued at $1,770.08 under a firm fixed-price contract. The award was issued on August 19, 2025, with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/19/25 |